BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 18952495)

  • 1. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient.
    Isegawa Y; Hara J; Amo K; Osugi Y; Takemoto M; Yamanishi K; Fukunaga R; Shibata M; Ohshima A; Horiguchi Y; Sugimoto N
    J Clin Virol; 2009 Jan; 44(1):15-9. PubMed ID: 18952495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase.
    Safronetz D; Petric M; Tellier R; Parvez B; Tipples GA
    J Med Virol; 2003 Nov; 71(3):434-9. PubMed ID: 12966551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and identification of U69 gene mutations encoded by ganciclovir-resistant human herpesvirus 6 using denaturing high-performance liquid chromatography.
    Nakano K; Nishinaka K; Tanaka T; Ohshima A; Sugimoto N; Isegawa Y
    J Virol Methods; 2009 Nov; 161(2):223-30. PubMed ID: 19559728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.
    Bounaadja L; Piret J; Goyette N; Boivin G
    J Clin Virol; 2013 Sep; 58(1):279-82. PubMed ID: 23871165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S; Hara J; Osugi Y; Ohta H; Matsuda Y; Fujisaki H; Sawada A; Kim JY; Sashihara J; Amou K; Miyagawa H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 2002 Apr; 29(7):595-8. PubMed ID: 11979309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCR with quenching probes enables the rapid detection and identification of ganciclovir-resistance-causing U69 gene mutations in human herpesvirus 6.
    Isegawa Y; Matsumoto C; Nishinaka K; Nakano K; Tanaka T; Sugimoto N; Ohshima A
    Mol Cell Probes; 2010 Aug; 24(4):167-77. PubMed ID: 20083192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
    J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance.
    De Bolle L; Manichanh C; Agut H; De Clercq E; Naesens L
    Antiviral Res; 2004 Oct; 64(1):17-25. PubMed ID: 15451175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
    Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
    Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
    Eckle T; Jahn G; Hamprecht K
    J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo.
    Manichanh C; Olivier-Aubron C; Lagarde JP; Aubin JT; Bossi P; Gautheret-Dejean A; Huraux JM; Agut H
    J Gen Virol; 2001 Nov; 82(Pt 11):2767-2776. PubMed ID: 11602788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain.
    Hamprecht K; Eckle T; Prix L; Faul C; Einsele H; Jahn G
    J Infect Dis; 2003 Jan; 187(1):139-43. PubMed ID: 12508158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development.
    Bonnafous P; Verbelen M; Petrella S; Deback C; Gautheret-Dejean A; Boutolleau D; Naesens L; Agut H
    Antiviral Res; 2010 Jun; 86(3):316-9. PubMed ID: 20298721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.
    Ogata M; Satou T; Kawano R; Goto K; Ikewaki J; Kohno K; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Saikawa T; Kadota JI
    Bone Marrow Transplant; 2008 Feb; 41(3):279-85. PubMed ID: 18037945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
    J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir.
    Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M
    Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
    Göhring K; Mikeler E; Jahn G; Rohde F; Hamprecht K
    Antivir Ther; 2008; 13(3):461-6. PubMed ID: 18572760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients.
    Ljungman P; Dahl H; Xu YH; Larsson K; Brytting M; Linde A
    Bone Marrow Transplant; 2007 Apr; 39(8):497-9. PubMed ID: 17334385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.
    Ogata M; Kikuchi H; Satou T; Kawano R; Ikewaki J; Kohno K; Kashima K; Ohtsuka E; Kadota J
    J Infect Dis; 2006 Jan; 193(1):68-79. PubMed ID: 16323134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.